Working… Menu

WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01659437
Recruitment Status : Completed
First Posted : August 7, 2012
Last Update Posted : September 26, 2019
University of Groningen
Faculté de Médecine P&M Curie, Paris-6 - Site Pitié-Salpêtrière, France
Drugs for Neglected Diseases
World Alliance for Wound and Lymphoedema Care, Switzerland
Inserm U892/CNRS 699 bactériologie, Université CHU;Angers- IRIS France
Institute of Tropical Medicine, Antwerp, Belgium
National Buruli ulcer Control Programme, Ghana Health Service, Accra, Ghana
School of Med Sciences, Kwame Nkrumah Univ of Sci & Techn, Kumasi, Ghana
Komfo Anokye Teaching Hospital
Kumasi Center for Collaborative Research into Tropical Medicine, Kumasi, Ghana
Plastic Surgery and Burns Centre, Korle-Bu Teaching Hospital, Accra, Ghana
University of Ghana
Noguchi Memorial Institute of Medical Research, Accra, Ghana
Program Nat de Lutte contre la Lèpre et l'UB;Ulcère de Buruli, Cotonou, Benin
Information provided by (Responsible Party):
Tjip van der Werf, University Medical Center Groningen

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2017
Actual Study Completion Date : January 2018
Publications automatically indexed to this study by Identifier (NCT Number):